Uptake of Lung Cancer Screening with Low-Dose Computed Tomography in China: A Multi-Centre Population-Based Study

Wei Cao,Fengwei Tan,Kuangyu Liu,Zheng Wu,Fei Wang,Yiwen Yu,Yan Wen,Chao Qin,Yongjie Xu,Liang Zhao,Wei Tang,Jiang Li,Xuesi Dong,Yadi Zheng,Zhuoyu Yang,Kai Su,Fang Li,Jufang Shi,Jiansong Ren,Yunyong Liu,Lianzheng Yu,Donghua Wei,Dong,Ji Cao,Shaokai Zhang,Shipeng Yan,Ning Wang,Lingbin Du,Wanqing Chen,Ni Li,Jie He
DOI: https://doi.org/10.1016/j.eclinm.2022.101594
IF: 15.1
2022-01-01
EClinicalMedicine
Abstract:Background Optimal uptake rates of low-dose computed tomography (LDCT) scans are essential for lung cancer screening (LCS) to confer mortality benefits. We aimed to outline the process model of the LCS programme in China, identify the high-risk individuals with low uptake based on a prospective multi-centre population-based cohort, and further explore associated structural characteristics.Methods A total of 221,955 individuals at high-risk for lung cancer from the National Lung Cancer Screening cohort were included. The logistic regression model was performed to identify the individual characteristics associated with the uptake of LCS, defined as whether the high-risk individual undertook LDCT scans in designated hospitals within six months following the initial risk assessment. The linear regression model was adopted to explore the structural characteristics associated with the uptake rates in 186 communities.
What problem does this paper attempt to address?